Price guide · Reviewed August 28, 2026

How to compare online GLP-1 providers in five steps

The fastest way to compare online GLP-1 providers is to make every company answer the same five questions. This turns a page full of “from” prices into a shortlist you can actually evaluate.

1. Define the medication path

Separate compounded semaglutide, compounded tirzepatide, FDA-approved semaglutide brands, and FDA-approved tirzepatide brands. Do not compare an oral starter offer with an injectable maintenance program as if they were the same product.

2. Normalize the money

Record medication, membership, consultation, labs, supplies, shipping, and any other required fee. Write down the first-month total, likely ongoing total, amount due today, and total commitment. If dose affects price, record the published range.

3. Inspect clinical access

Identify who reviews the intake, whether visits are video or asynchronous, how follow-up works, who handles side-effect questions, and whether a clinician can change the treatment plan. A prescription is never guaranteed and the clinical decision should remain independent.

4. Verify pharmacy and availability

Ask which licensed pharmacy may dispense the medication, whether that varies by state, how medication is shipped, and what happens during a delay. Provider-wide availability language may still have treatment-specific exceptions.

5. Read the exit terms

Check renewal timing, cancellation deadlines, refund rules, prepaid obligations, and what happens if you are not medically eligible. Save the terms shown at the time of purchase. A low monthly equivalent is less attractive if the entire term is nonrefundable and due upfront.

Where the numbers come from

We use publicly accessible provider-owned pricing pages and preserve the condition attached to each figure. See the full methodology, source list, and current provider comparison.

Medical note: This content is for price research, not medical advice. Prescription medications require a licensed clinician’s review. Compounded drugs are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality.